万维提示：
1、投稿方式：在线投稿。
2、期刊网址：http://www.asianbiomed.org/
或：https://sciendo.com/journal/ABM
3、投稿网址：https://www.editorialmanager.com/abm/
4、官网邮箱：abmjournal@chula.ac.th
5、官网电话：(+66) 2-256-4479
6、期刊刊期：双月刊，逢双月出版。
2021年10月23日星期六
投稿须知【官网信息】
Asian Biomedicine — Guide for Authors 2021
About: Asian Biomedicine: Research, Reviews and News (ISSN 1905-7415 print; 1875-855X electronic online) is published in one volume (of 6 bimonthly issues) a year since 2007. Asian Biomedicine (U.S. National Library of Medicine [NLM] and International Organization for Standardization [ISO] title abbreviation: Asian Biomed [Res Rev News]) is an open access journal supported by the Commission on Higher Education, Ministry of Education, Thailand, with editorial offices at and ownership by the Faculty of Medicine, Chulalongkorn University, Bangkok.
The content of the journal is open to all with full access online without charge. No submission charge, or article processing or page charges (APCs), are levied on authors or their institutions. The owners of Asian Biomedicine will bear the cost of publication of articles, but will publish color Figures in print at their discretion.
Asian Biomedicine is intended to serve the biomedical and health sciences community of the entire Asian region with an international audience and is published in cooperation with Sciendo (www.sciendo.com), a brand of De Gruyter—Poland, a subsidiary of its parent company Walter de Gruyter GmbH (www.degruyter.com) devoted to academic publication and services, with offices in Warsaw.
Aims and scope: Asian Biomedicine is an international, general medical and biomedical multidisciplinary journal that aims to publish original peer-reviewed contributions dealing with various topics in the biomedical and health sciences, ranging from basic experimental to clinical aspects. The work and authorship must either be strongly affiliated with a country in Asia or have specific importance for and relevance to the Asian region, or both. The Journal will publish reviews, original experimental studies, observational studies; technical and clinical (case) reports, practice guidelines, historical perspectives of Asian biomedicine, clinicopathological conferences (CPCs), and commentaries.
Innovative investigations, including basic research; clinical trials; studies of diagnostic accuracy; studies relating to behavioral, therapeutic, or epidemiological aspects of medicine; public health; clinical guidelines; standards of health care; and indigenous diseases, are welcomed. We invite guest editorials on occasion.
Audience: Asian Biomedicine is intended for a broad and
international audience, primarily those in the health professions, including researchers, physician practitioners, basic medical scientists, dentists, educators, administrators; those in the assistive professions, such as nurses; and the many types of allied health professionals in research and in health care delivery systems, including those in training.
This Guide for Authors includes our ethical and policy guidelines, and it is revised periodically by the Editors as needed. Authors should consult a recent issue of the Journal or visit www.asianbiomed.org for the latest version of these guidelines. Author(s) may be asked by the Editors to revise, without any peer review, any manuscript or submission not prepared according to these guidelines.
1 Article categories
Reviews, Minireviews, Practice guidelines, Original articles, History of Asian biomedicine, Clinical (case) reports, Clinical vignettes, Technical reports, Brief communications (original), Controversies in biomedicine, Commentary, New developments, CPCs, and Letters to the Editor will be considered for publication (Table 1).
1.1 Reviews
Asian Biomedicine aims to provide narrative reviews as background for those in training, including graduate students and house officers/residents; for the continuing education of practitioners and researchers; and for others who wish to have an overview of the current status of a field. Authors are encouraged to submit reviews of various topics of relevance to Asia.
Reviews should describe the current state of knowledge or practice, integrating recent advances with accepted principles and practice, or substantially summarizing and analyzing the consensus view of controversial issues in knowledge or practice. Reviews should aim to be critical and to provide the reader with a balanced overview of an important and topical subject in biomedicine or health sciences, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention.
They should cover aspects of a topic for which scientific consensus exists, in addition to aspects that remain controversial and are the subject of ongoing scientific research. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes.
The Editors require reviews to be an original synthesis of ideas. The preparation of a review must, by its very nature, rely heavily on the ideas, observations, and reports of others. Therefore, it is important that the authors exercise care in citing and quoting other articles. This precaution applies also to the use of one’s own published writing. The following guidelines are intended primarily to protect our authors from inadvertent infringements of copyright, any appearance of plagiarism, or accidental bias in assembling bibliographies.
……
更多详情：
https://sciendo-parsed-data-feed.s3.eu-central-1.amazonaws.com/ABM/Guide_for_Authors.pdf
